Grant: Planning and Dissemination Grant - Institute Community Support
University of Calgary
$20,000.00
Canadian Innovative Methods involving Patients and Researchers in Outcome ImprovEments for Chronic Kidney Disease (Can-IMPROVE CKD): a strategic planning meeting
FY 2014-15
Summary
Kidney disease affects 1 in 10 and currently there is no cure. The best way to improve health outcomes for those with kidney disease is to avoid end-stage kidney failure. However, most research focuses on dialysis and transplantation, which represents only 2% of patients with kidney disease. Patients with earlier stages of kidney disease have identified the follow research priorities as important: preventing or delaying the onset of kidney disease, slowing the progression of kidney disease and alleviating symptoms in patients with kidney disease. In order to best address these research priorities, a coordinated national approach, involving patients, clinicians and health care decision-makers is needed. Work has begun on a pan-Canadian Kidney Clinical Research network: Can-IMPROVE CKD, Canadian Innovative Methods involving Patients and Researchers in Outcome ImprovEments for chronic kidney disease (CKD). Can-IMPROVE CKD will focus on patient-centered management of patients with kidney disease and will engage patients in research in a meaningful way. Can-IMPROVE CKD has completed significant background work, including forming a steering committee involving patients, caregivers and health care decision makers and health care funders.
In order to continue moving this network forward, we are seeking funding to support a 1.5-day strategic meeting to bring together a larger group of 35 - 38 patients, health care decision-makers, and researchers from across Canada. This will ensure that the needs of patients, their clinicians and health care funders will be met by Can-IMPROVE CKD, will allow us to establish committees and workgroups and will ensure that the detailed study questions and plans that are developed address the broad priority areas that have been established to date.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
314903
Name
Manns Braden J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Planning and Dissemination - INMD
Projecttitle
Canadian Innovative Methods involving Patients and Researchers in Outcome ImprovEments for Chronic Kidney Disease (Can-IMPROVE CKD): a strategic planning meeting
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Calgary
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Chronic Kidney Disease; Clinicians; Patients; Research Priorities; Strategic Planning Meeting
Abstract
Kidney disease affects 1 in 10 and currently there is no cure. The best way to improve health outcomes for those with kidney disease is to avoid end-stage kidney failure. However, most research focuses on dialysis and transplantation, which represents only 2% of patients with kidney disease. Patients with earlier stages of kidney disease have identified the follow research priorities as important: preventing or delaying the onset of kidney disease, slowing the progression of kidney disease and alleviating symptoms in patients with kidney disease. In order to best address these research priorities, a coordinated national approach, involving patients, clinicians and health care decision-makers is needed. Work has begun on a pan-Canadian Kidney Clinical Research network: Can-IMPROVE CKD, Canadian Innovative Methods involving Patients and Researchers in Outcome ImprovEments for chronic kidney disease (CKD). Can-IMPROVE CKD will focus on patient-centered management of patients with kidney disease and will engage patients in research in a meaningful way. Can-IMPROVE CKD has completed significant background work, including forming a steering committee involving patients, caregivers and health care decision makers and health care funders.
In order to continue moving this network forward, we are seeking funding to support a 1.5-day strategic meeting to bring together a larger group of 35 - 38 patients, health care decision-makers, and researchers from across Canada. This will ensure that the needs of patients, their clinicians and health care funders will be met by Can-IMPROVE CKD, will allow us to establish committees and workgroups and will ensure that the detailed study questions and plans that are developed address the broad priority areas that have been established to date.
Competitiondate
201408
Approvedterm2
1 yr 0 mth
Pinamesdelim
Manns, Braden J; Levin, Adeera
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $20,000~ $0~